Stay updated with breaking news from Nasdaq Prtk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. A number of other equities analysts have also recently weighed in on the stock. HC Wainwright cut shares of Paratek Pharmaceuticals from […]
HC Wainwright lowered shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a neutral rating in a research note released on Wednesday morning, The Fly reports. Several other equities analysts have also recently commented on the stock. BTIG Research decreased their price target on shares of Paratek Pharmaceuticals from $24.00 to […]
StockNews.com upgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a hold rating to a buy rating in a report issued on Tuesday. A number of other research firms have also weighed in on PRTK. BTIG Research cut their price objective on shares of Paratek Pharmaceuticals from $24.00 to $5.00 in a research note […]
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) was downgraded by HC Wainwright from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, The Fly reports. Several other research analysts have also weighed in on PRTK. StockNews.com raised Paratek Pharmaceuticals from a “hold” rating to a “buy” rating in a research […]
HC Wainwright downgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a neutral rating in a report issued on Wednesday, The Fly reports. Several other research firms also recently commented on PRTK. Jefferies Financial Group downgraded shares of Paratek Pharmaceuticals from a buy rating to a hold rating in a […]